Effect of growth hormone treatment on quality of life in Japanese children with growth hormone deficiency: An analysis from a prospective observational study

Toshiaki Tanaka, Tomonobu Hasegawa, Keiichi Ozono, Hiroyuki Tanaka, Susumu Kanzaki, Susumu Yokoya, Kazuo Chihara, Noriyuki Iwamoto, Yoshiki Seino

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The aim of this study was to assess changes in quality of life (QoL) in Japanese children with GH deficiency (GHD) after 12 mo of GH treatment or with idiopathic short stature (ISS) after 12 mo without treatment. Children with GHD were treated with GH after enrollment. Outcome measures included the parent-rated Child Behavior Checklist (CBCL), the Youth Self-Report Form (YSR), and height standard deviation scores (SDS). Total CBCL scores significantly decreased in children with GHD (n = 152, mean change (standard deviation [SD]) = -3.42 [11.21]) and ISS (n = 129, mean change = -4.82 [10.09]) after 12 mo (p < 0.001). Total YSR scores (mean change = -9.21 [14.07]) and height SDS (mean change = 0.35 [0.38]) significantly decreased in children with GHD (p < 0.001), but were unchanged in children with ISS. The change in total YSR score was significantly correlated with the change in height SDS in children with GHD (r = -0.516, p = 0.003). Our findings demonstrate that GH treatment can improve QoL in Japanese children with GHD. The correlation between the changes in total YSR score and height SDS demonstrated that increased height resulted in improved QoL.

Original languageEnglish
Pages (from-to)83-92
Number of pages10
JournalClinical Pediatric Endocrinology
Volume23
Issue number3
DOIs
Publication statusPublished - 2014

Fingerprint

Growth Hormone
Observational Studies
Quality of Life
Prospective Studies
Self Report
Child Behavior
Checklist
Therapeutics
Outcome Assessment (Health Care)

Keywords

  • Child behavior checklist
  • GH deficiency
  • GH treatment
  • Idiopathic short stature
  • Youth self-report

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Pediatrics, Perinatology, and Child Health

Cite this

Effect of growth hormone treatment on quality of life in Japanese children with growth hormone deficiency : An analysis from a prospective observational study. / Tanaka, Toshiaki; Hasegawa, Tomonobu; Ozono, Keiichi; Tanaka, Hiroyuki; Kanzaki, Susumu; Yokoya, Susumu; Chihara, Kazuo; Iwamoto, Noriyuki; Seino, Yoshiki.

In: Clinical Pediatric Endocrinology, Vol. 23, No. 3, 2014, p. 83-92.

Research output: Contribution to journalArticle

Tanaka, Toshiaki ; Hasegawa, Tomonobu ; Ozono, Keiichi ; Tanaka, Hiroyuki ; Kanzaki, Susumu ; Yokoya, Susumu ; Chihara, Kazuo ; Iwamoto, Noriyuki ; Seino, Yoshiki. / Effect of growth hormone treatment on quality of life in Japanese children with growth hormone deficiency : An analysis from a prospective observational study. In: Clinical Pediatric Endocrinology. 2014 ; Vol. 23, No. 3. pp. 83-92.
@article{3aca718bfa17492d8c7c4e1b99bae218,
title = "Effect of growth hormone treatment on quality of life in Japanese children with growth hormone deficiency: An analysis from a prospective observational study",
abstract = "The aim of this study was to assess changes in quality of life (QoL) in Japanese children with GH deficiency (GHD) after 12 mo of GH treatment or with idiopathic short stature (ISS) after 12 mo without treatment. Children with GHD were treated with GH after enrollment. Outcome measures included the parent-rated Child Behavior Checklist (CBCL), the Youth Self-Report Form (YSR), and height standard deviation scores (SDS). Total CBCL scores significantly decreased in children with GHD (n = 152, mean change (standard deviation [SD]) = -3.42 [11.21]) and ISS (n = 129, mean change = -4.82 [10.09]) after 12 mo (p < 0.001). Total YSR scores (mean change = -9.21 [14.07]) and height SDS (mean change = 0.35 [0.38]) significantly decreased in children with GHD (p < 0.001), but were unchanged in children with ISS. The change in total YSR score was significantly correlated with the change in height SDS in children with GHD (r = -0.516, p = 0.003). Our findings demonstrate that GH treatment can improve QoL in Japanese children with GHD. The correlation between the changes in total YSR score and height SDS demonstrated that increased height resulted in improved QoL.",
keywords = "Child behavior checklist, GH deficiency, GH treatment, Idiopathic short stature, Youth self-report",
author = "Toshiaki Tanaka and Tomonobu Hasegawa and Keiichi Ozono and Hiroyuki Tanaka and Susumu Kanzaki and Susumu Yokoya and Kazuo Chihara and Noriyuki Iwamoto and Yoshiki Seino",
year = "2014",
doi = "10.1297/cpe.23.83",
language = "English",
volume = "23",
pages = "83--92",
journal = "Clinical Pediatric Endocrinology",
issn = "0918-5739",
publisher = "Jeff Corporation Co. Ltd",
number = "3",

}

TY - JOUR

T1 - Effect of growth hormone treatment on quality of life in Japanese children with growth hormone deficiency

T2 - An analysis from a prospective observational study

AU - Tanaka, Toshiaki

AU - Hasegawa, Tomonobu

AU - Ozono, Keiichi

AU - Tanaka, Hiroyuki

AU - Kanzaki, Susumu

AU - Yokoya, Susumu

AU - Chihara, Kazuo

AU - Iwamoto, Noriyuki

AU - Seino, Yoshiki

PY - 2014

Y1 - 2014

N2 - The aim of this study was to assess changes in quality of life (QoL) in Japanese children with GH deficiency (GHD) after 12 mo of GH treatment or with idiopathic short stature (ISS) after 12 mo without treatment. Children with GHD were treated with GH after enrollment. Outcome measures included the parent-rated Child Behavior Checklist (CBCL), the Youth Self-Report Form (YSR), and height standard deviation scores (SDS). Total CBCL scores significantly decreased in children with GHD (n = 152, mean change (standard deviation [SD]) = -3.42 [11.21]) and ISS (n = 129, mean change = -4.82 [10.09]) after 12 mo (p < 0.001). Total YSR scores (mean change = -9.21 [14.07]) and height SDS (mean change = 0.35 [0.38]) significantly decreased in children with GHD (p < 0.001), but were unchanged in children with ISS. The change in total YSR score was significantly correlated with the change in height SDS in children with GHD (r = -0.516, p = 0.003). Our findings demonstrate that GH treatment can improve QoL in Japanese children with GHD. The correlation between the changes in total YSR score and height SDS demonstrated that increased height resulted in improved QoL.

AB - The aim of this study was to assess changes in quality of life (QoL) in Japanese children with GH deficiency (GHD) after 12 mo of GH treatment or with idiopathic short stature (ISS) after 12 mo without treatment. Children with GHD were treated with GH after enrollment. Outcome measures included the parent-rated Child Behavior Checklist (CBCL), the Youth Self-Report Form (YSR), and height standard deviation scores (SDS). Total CBCL scores significantly decreased in children with GHD (n = 152, mean change (standard deviation [SD]) = -3.42 [11.21]) and ISS (n = 129, mean change = -4.82 [10.09]) after 12 mo (p < 0.001). Total YSR scores (mean change = -9.21 [14.07]) and height SDS (mean change = 0.35 [0.38]) significantly decreased in children with GHD (p < 0.001), but were unchanged in children with ISS. The change in total YSR score was significantly correlated with the change in height SDS in children with GHD (r = -0.516, p = 0.003). Our findings demonstrate that GH treatment can improve QoL in Japanese children with GHD. The correlation between the changes in total YSR score and height SDS demonstrated that increased height resulted in improved QoL.

KW - Child behavior checklist

KW - GH deficiency

KW - GH treatment

KW - Idiopathic short stature

KW - Youth self-report

UR - http://www.scopus.com/inward/record.url?scp=84905656606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905656606&partnerID=8YFLogxK

U2 - 10.1297/cpe.23.83

DO - 10.1297/cpe.23.83

M3 - Article

AN - SCOPUS:84905656606

VL - 23

SP - 83

EP - 92

JO - Clinical Pediatric Endocrinology

JF - Clinical Pediatric Endocrinology

SN - 0918-5739

IS - 3

ER -